SS
AMPH icon

Sunbelt Securities’s Amphastar Pharmaceuticals AMPH Stock Holding History

Sunbelt Securities’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$274 Sell
14
-8
-36% -$196 ﹤0.01% 2439
2025
Q4 		$589 Hold
22
– – ﹤0.01% 2207
2025
Q3 		$586 Buy
+22
New +$568 ﹤0.01% 2182

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Sunbelt Securities's AMPH Position: Q1 2026 in Review

Sunbelt Securities reduced its Amphastar Pharmaceuticals (AMPH) stake by 36% in Q1 2026, selling an estimated $196 and leaving 14 shares worth $274. The position accounts for ﹤0.01% of the portfolio, ranked #2439.

Sunbelt Securities first reported a position in AMPH in Q3 2025 and has held it in 3 quarters since. The position peaked at $589 in Q4 2025. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

  • Sunbelt Securities held 14 shares of Amphastar Pharmaceuticals worth $274 as of Q1 2026.
  • Sunbelt Securities sold 8 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $196.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2439 holding.
  • Sunbelt Securities first reported a position in Amphastar Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Sunbelt Securities's Amphastar Pharmaceuticals position peaked at $589 in Q4 2025.
  • 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.